Latest 10-K annual reports

NV5 Global, Inc. has filed an Amendment No. 2 to its Annual Report on Form 10-K for the fiscal year ended December 28, 2024, primarily to include previously omitted beneficial ownership information and updated Sarbanes-Oxley certifications.

Park Aerospace Corp. reported an 11% increase in net sales for fiscal year 2025, driven by aerospace market demand, but saw a 21% decline in net earnings due to a storm damage charge and a significant deferred tax provision on foreign earnings.

Phoenix Motor Inc. reported a net income of $7.9 million in 2024, primarily driven by a bargain purchase gain from the Proterra acquisition, despite continued operating losses and a Nasdaq delisting, as the company focuses on strategic integration and cost reduction.

Universal Corporation announced a 7% increase in consolidated revenues and a 5% rise in operating income for fiscal year 2025, driven by strong performance in both its Tobacco and Ingredients segments, despite a 21% drop in diluted earnings per share and the identification of a new material weakness in internal controls.

Streamline Health Solutions, Inc. has filed an amendment to its annual report, providing comprehensive details on corporate governance, executive compensation, and director appointments, while disclosing that named executive officers did not receive cash bonuses for fiscal year 2024 due to not meeting adjusted EBITDA targets.

Kirklands, Inc. filed an amendment to its annual report to include detailed information on executive compensation and corporate governance, disclosing a significant fiscal 2024 EBITDA loss and outlining its strategic partnership with Beyond, Inc.

Hamilton Lane Incorporated announced a significant surge in net income and revenues for fiscal year 2025, primarily fueled by a near-doubling of incentive fees and continued strong growth in assets under management and advisement.

eBay Inc. has filed an Amendment No. 1 to its 2024 Annual Report on Form 10-K to incorporate the financial statements of Adevinta ASA, a significant equity method investee, as required by SEC regulations.

TriSalus Life Sciences, an oncology-focused medical technology company, reported a significant reduction in net loss and strong revenue growth for the fiscal year ended December 31, 2024, but disclosed substantial doubt about its ability to continue as a going concern due to recurring losses and insufficient liquidity without further financing.

Bimergen Energy Corporation, formerly Bitech Technologies, reported a significant increase in net loss for fiscal year 2024, driven by operational expansion into utility-scale battery energy storage and solar projects following the acquisition of Emergen Energy LLC, while also announcing a new joint venture with RelyEZ Energy Group for 2 GW of BESS projects.

Kyndryl Holdings, Inc. announced a return to net income profitability and robust signings growth in fiscal year 2025, signaling progress in its strategic transformation despite a continued decline in overall revenue.

Canopy Growth Corporation reported a significant increase in net loss for fiscal year 2025, reaching C$604.1 million, despite improvements in gross margin and a reduction in Adjusted EBITDA loss, as the company continues its strategic shift towards an asset-right model and U.S. market entry.

iCoreConnect Inc. reported a doubling of its net loss to over $31 million in 2024, faces Nasdaq delisting, and has substantial doubt about its ability to continue as a going concern, despite revenue growth.

Loop Industries, a technology company focused on infinite PET recycling, reported a significant increase in revenue for the fiscal year ended February 28, 2025, primarily due to a new European technology licensing agreement, while continuing to advance its global commercialization strategy despite terminating a key joint venture in South Korea.

Artificial Intelligence Technology Solutions Inc. (AITX) announced a remarkable 175% surge in annual revenue for the fiscal year ended February 28, 2025, driven by strong demand for its AI-powered security solutions, yet faces critical financial challenges including a substantial accumulated deficit and auditor-raised concerns about its ability to continue as a going concern.

NextTrip, Inc., an early-stage travel technology company, reported a substantial net loss of over $10 million for fiscal year 2025, raising significant going concern doubts, even as it expands its booking platform and media properties through strategic acquisitions and partnerships.

Autonomix Medical, a development-stage medical device company, reported a $50.4 million accumulated deficit and negative cash flows, raising substantial doubt about its ability to continue as a going concern, despite positive early clinical trial results for its novel nerve-sensing and ablation technology.

Dorian LPG Ltd. announced a substantial decrease in revenues and net income for the fiscal year ended March 31, 2025, primarily driven by lower spot market rates and increased operating expenses, despite strategic investments in fleet modernization and a new ammonia-ready carrier.

STERIS plc announced a 6.2% increase in total revenues to $5.46 billion for fiscal year 2025, driven by robust performance in its Healthcare and Applied Sterilization Technologies segments, alongside a substantial reduction in debt after the sale of its Dental business.

NGL Energy Partners LP reports full-year results, marking a strategic shift towards Water Solutions following the sale of its refined products business and certain natural gas liquids terminals.

Charlies Holdings, Inc. faced a challenging 2024, reporting a significant 47.7% drop in revenue and a near doubling of its net loss, raising substantial doubt about its ability to continue as a going concern, despite strategic shifts towards non-nicotine products and ongoing regulatory compliance efforts.

Alixo-Yolloo Corporation, a music recognition service provider, reported a 75% increase in revenue for fiscal year 2025, but also a 234% surge in net losses, raising substantial doubt about its ability to continue as a going concern.

Medinotec, Inc. announced a significant financial turnaround in its fiscal year ended February 28, 2025, reporting an 81.5% surge in revenue and a shift from a net loss to a substantial net income, primarily fueled by new distribution agreements in South Africa and successful commercialization of its Trachealator device in the United States.

American Vanguard Corporation announced a substantial net loss of $126.3 million for 2024, driven by significant nonrecurring charges and a decline in sales, as the company undergoes a major business and digital transformation under new leadership.

Roivant Sciences Ltd. reported a net loss of $356.7 million for fiscal year 2025, primarily due to increased operating expenses and the absence of a large one-time gain from the prior year's Telavant divestiture, despite significant clinical progress across its diverse biopharmaceutical pipeline.

Immunovant, a clinical-stage immunology company, reported significant progress in its pipeline, initiating multiple registrational trials for its potentially best-in-class FcRn inhibitor IMVT-1402 across several autoimmune indications, while also announcing positive Phase 3 results for batoclimab in Myasthenia Gravis.

FingerMotion, Inc. reported a widened net loss of $5.1 million for fiscal year 2025, driven by a decline in its core telecommunications segment and increased operating expenses, despite initial revenue contributions from new Smart Mobility and DaGe platforms.

e.l.f. Beauty, Inc. announced a 28% increase in net sales to $1.31 billion for fiscal year 2025, driven by strong performance across retail and e-commerce channels, while also revealing a definitive agreement to acquire rhode for up to $1 billion.

U-Haul Holding Company announced a substantial drop in net earnings for fiscal year 2025, primarily due to increased operating expenses, higher depreciation from fleet additions, and reduced profits from the sale of used rental equipment, despite overall revenue growth.

Columbus McKinnon Corporation reported a net loss of $5.1 million for fiscal year 2025, a significant decline from the prior year's profit, driven by lower sales volume, facility consolidation costs, and a substantial non-cash pension settlement charge, while simultaneously pursuing a transformative $2.7 billion acquisition of Kito Crosby Limited.